Skip to main content
Clinical Trials/NCT00955903
NCT00955903CompletedPhase 3

Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults

University of Alabama at Birmingham2 sites in 1 country167 target enrollmentStarted: June 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
167
Locations
2
Primary Endpoint
Change in Abdominal Fat Mass

Study Overview

Brief Summary

The investigators want to determine if the benefits of weight loss outweigh the potential risk in a group of older adults. The investigators will test the hypothesis that changes in diet composition alone or in conjunction with weight loss will have a significant effect on fat stores, and as a result, improve cardiometabolic risk factors and functional status in adults 65 and older.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
65 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • at least 65 years of age
  • BMI 27 - 42 kg/m2 - at increased health risk (taking at least 1 medication for hypertension, hyperlipidemia, or type 2 diabetes)

Exclusion Criteria

  • difficulties chewing or swallowing food
  • digestive diseases that may affect the ability to follow a high fiber diet
  • cognitive impairment
  • depression
  • recent weight change (+/- 10 lbs in the last 12 months)
  • poorly controlled blood pressure
  • history of non-skin cancer in last 5 years
  • cardiovascular disease event in past 6 months or severe pulmonary disease or renal failure
  • major liver dysfunction
  • current smoker or quit less than months prior
  • history of prior surgical procedures for weight control or liposuction
  • use of estrogen or testosterone replacement therapy
  • current use of insulin or sulfonylurea agents
  • current use of corticosteroids > 5 days/month on average
  • current use of medications for treatment of psychosis or manic-depressive illness
  • use of weight-loss medications in previous 3 months
  • dependence on others for food procurement or preparation
  • ischemic changes on exercise treadmill test

Arms & Interventions

Weight Loss

Experimental

Participants receive Exercise and Reduced Calorie Diet Interventions

Intervention: Exercise (Behavioral)

Weight Loss

Experimental

Participants receive Exercise and Reduced Calorie Diet Interventions

Intervention: Reduced Calorie Diet (Behavioral)

Control

Active Comparator

Participants receive Exercise Intervention

Intervention: Exercise (Behavioral)

Weight Maintenance

Active Comparator

Participants receive Exercise and a Weight Maintenance Diet Interventions

Intervention: Exercise (Behavioral)

Weight Maintenance

Active Comparator

Participants receive Exercise and a Weight Maintenance Diet Interventions

Intervention: Weight Maintenance Diet (Behavioral)

Outcomes

Primary Outcomes

Change in Abdominal Fat Mass

Time Frame: Baseline to 1 year

Visceral adipose tissue (cm3) by MRI. Change is calculated as value at baseline minus value at 1 year

Secondary Outcomes

  • Cardiometabolic Risk Factors(Baseline to 1 year)
  • Weight Change/Maintenance(Baseline to 1 year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jamy Ard, MD

Associate Professor

University of Alabama at Birmingham

Study Sites (2)

Loading locations...

Similar Trials

Calorie Restriction and Changes in Body... | Clinical Trial